NIDA

Virtual options, such as social media, hold promise as sustainable and scalable intervention strategies to promote access to smoking cessation treatment among AN people, and other groups who experience a disproportionate burden of tobacco-related morbidity/mortality.

This study leverages ABCD’s infrastructure, cohort, and existing protocol to rapidly characterize the impacts of the COVID-19 pandemic on each child in the study, including the impact on their families and communities.

This study leverages the Adolescent Brain Cognitive Development (ABCD) cohort to examine the impacts that the COVID-19 pandemic has had on developmental trajectories of brain functioning, cognition, substance use, academic achievement, social functioning, and physical and mental health in children.

The overarching goal of the parent grant is to test the impact of an empirically derived implementation strategy—under real-world conditions and across youth public service systems—on successful adoption and sustainment of evidence-based substance use programs.

Woebot for Substance Use Disorders (W-SUDs) is a two-phase NIDA-funded SBIR. Presently, W-SUDs, a novel digital therapeutic, is being evaluated in the Phase I pilot. Phase II will investigate W-SUDs’s efficacy compared to an active control condition.

There is an urgent need to longitudinally study the impact of the pandemic on pregnant women and the care they receive, and to understand the consequences for their children’s birth outcomes and neurobehavioral development.